Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial amidoxime-reducing component 1 (MTARC1, also known as MARC1) is a molybdenum cofactor-containing enzyme anchored to the outer mitochondrial membrane. It functions as part of a three-component electron transfer chain alongside cytochrome b5 and NADH-dependent cytochrome b5 reductase to catalyze the reduction of N-hydroxylated and N-oxygenated compounds, including various prodrugs and endogenous substrates. Human genetic studies have strongly validated MTARC1 as a therapeutic target, demonstrating that loss-of-function variants (such as the common p.A165T missense variant) are highly protective against metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction-associated steatohepatitis (MASH), and all-cause liver cirrhosis. Suppressing MTARC1 expression in hepatocytes reduces intracellular lipid accumulation, enhances fatty acid beta-oxidation, and mitigates liver inflammation and fibrosis. Consequently, therapeutic strategies targeting MTARC1, primarily utilizing liver-targeted small interfering RNAs (siRNAs) like NNC0581-0001 and OLX75016, are currently in clinical development for the treatment of MASH and other cardiometabolic disorders.
RNA interference
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial amidoxime-reducing component 1 (MTARC1).